Some Ebola guidelines questioned

Experts questions questioning calls for suspending certain routine lab tests


Experts are questioning aspects of some of the Ebola guidelines that go beyond current Centers for Disease Control and Prevention (CDC) recommendations, especially those that call for suspending certain routine lab tests, according to an article on Infection Control Today.

A commentary in the journal Transfusion suggests that most individuals with suspected Ebola will have a fever due to another cause, and forgoing such testing may compromise patients' health more than any reduction in the risks to laboratory personnel.

The article says that all laboratory directors must work with infection control and safety experts to evaluate their hospital policies on potentially infectious patients to provide a safe environment.

Read the article.

 

 



December 12, 2014


Topic Area: Safety


Recent Posts

The Future of Backup Power Systems in Healthcare Facilities

Manufacturers discuss what trends are shaping the future of backup power systems in healthcare.


Infection Control is Key to Ongoing Measles Outbreak

Infection control is essential to protecting both patients and staff from contracting measles.


Kaiser Permanente to Open New Parker Medical Offices

It also announced it's in the early stages of planning a rebuild and expansion of its Westminster Medical Offices.


Skanska Completes Renovation for New Sutter Health Care Center

The new facility will provide internal medicine, family medicine, pediatrics, as well as lab and imaging services.


Probiotic Cleaners: The Start of a Cleaning Revolution?

Advantages of probiotic cleaning include fewer resistant genes and cost savings through decreased antibiotic use.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.